Related Experiment Video
Updated: Aug 29, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Unresolved Systemic Inflammation, Long COVID, and the Common Pathomechanisms of Somatic and Psychiatric Comorbidity
Chih-Sung Liang1,2, Piotr Gałecki3, Kuan-Pin Su4,5,6
1Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, Taipei 112, Taiwan.
Abstract:
Monoamine hypothesis is an overestimated hypothesis of major depressive disorder (MDD), and the treatments and biomarkers that target it only show modest effect in randomized controlled trials+ (RCTs) or case-control studies [...].
Insights
The monoamine hypothesis for major depressive disorder (MDD) is likely overestimated, as treatments targeting it show limited effectiveness. New research directions are needed to understand and treat MDD more effectively.
Area of Science:
- Neuroscience
- Psychiatry
- Molecular Biology
Background:
- The prevailing monoamine hypothesis of major depressive disorder (MDD) suggests that reduced monoamine neurotransmission underlies the condition.
- Treatments and biomarkers based on the monoamine hypothesis have yielded modest effects in clinical trials.
Discussion:
- The effectiveness of monoamine-targeted treatments in randomized controlled trials (RCTs) and case-control studies is limited.
- This suggests that the monoamine hypothesis may overestimate the role of monoamines in MDD pathophysiology.
Key Insights:
- The monoamine hypothesis's central role in understanding MDD is being questioned due to modest treatment outcomes.
- Current therapeutic strategies and diagnostic biomarkers for MDD may require re-evaluation.
Outlook:
- Future research should explore alternative hypotheses and novel therapeutic targets beyond the monoamine system.
- Developing more effective biomarkers and treatments for MDD necessitates a broader understanding of its complex biological underpinnings.
More Related Videos
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
07:48Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: